Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details)

v3.22.2.2
Summary of Significant Accounting Policies (Details) - shares
 3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Merger agreement        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Common stock issued (in shares)       3,729,730
Stock Options [Member] | Merger agreement        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Common stock issued (in shares)     516,025  
Stock Options [Member] | Merger agreement | GEM Warrant [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Shares excluded from computation of diluted net loss per share     1,044,453  
Common stock warrant [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Shares excluded from computation of diluted net loss per share 17,521,753 9,305,790 17,521,753 9,305,790
Earnout Shares        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Shares excluded from computation of diluted net loss per share 22,209,280 22,209,280 22,209,280 22,209,280
Earnout Shares | Merger agreement        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Shares excluded from computation of diluted net loss per share     185,472  
Earnout Shares from exercised Substitute Options and Substitute Warrants        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Shares excluded from computation of diluted net loss per share 1,229,925 1,229,925 1,229,925 1,229,925